Doctor profile · Federal record
Dr. Mary Parker, M.D.
Specialist (CMS: Dermatology) · Houston, TX
- NPI 1568773273
- Accepts Medicare
- MIPS 96.3 / 100 · 2023
- 16 yrs in practice
- Female
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
7737 Southwest Fwy, Suite 350
Houston, TX 770741807
(713) 981-4444
fax (713) 981-5548
Credentials & registration
- NPI registered
- June 2010 — 16 yrs on file
- Profile last updated
- June 23, 2014
- Year of graduation
- 2010 — 16 yrs since
- Specialty taxonomy
- 174400000X — NUCC code
- State license (1)
- Texas #Q0530
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1568773273. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
2,036
Distinct HCPCS
10
Medicare allowed
$114,430
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 833 | 137 | $7 | |
17000 |
Destruction of precancer skin growth, 1 growth | 286 | 188 | $50 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 280 | 202 | $90 | |
17110 |
Destruction of skin growth, 1-14 growths | 157 | 121 | $115 | |
11102 |
Biopsy of related skin growth, first growth | 153 | 119 | $88 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 139 | 92 | $128 | |
11103 |
Biopsy of related skin growth, each additional growth | 59 | 36 | $50 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 50 | 44 | $57 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 47 | 31 | $174 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 20 | 20 | $113 |
In context: peer comparison
Among 28 peers in Houston Specialist, average services per provider: 166. This provider delivers 12× the peer median.Open Payments
Industry payments received
All-time total
$1,669
Transactions
77
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 13 | $230.24 | |
| Amgen INC. | 7 | $206.76 | |
| Janssen Biotech, INC. | 9 | $184.94 | |
| Novartis Pharmaceuticals Corporation | 8 | $160.70 | |
| Arcutis Biotherapeutics, INC. | 9 | $145.21 | |
| Regeneron Healthcare Solutions, INC. | 5 | $125.28 | |
| E.R. Squibb & Sons, L.L.C. | 5 | $115.24 | |
| Incyte Corporation | 3 | $73.78 | |
| Leo Pharma INC. | 3 | $70.65 | |
| Galderma Laboratories, L.P. | 4 | $63.88 | |
| Genzyme Corporation | 3 | $60.37 | |
| Lilly USA, LLC | 2 | $47.71 | |
| Ucb, INC. | 2 | $42.06 | |
| Sun Pharmaceutical Industries INC. | 2 | $34.92 | |
| Dermavant Sciences, INC. | 2 | $32.97 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
304
Patients
103
Total drug cost
$12,275
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 51 | 38 | $504 |
| Mupirocin | Generic | 35 | 26 | $249 |
| Ketoconazole | Generic | 28 | 17 | $600 |
| Clobetasol Propionate | Generic | 26 | 0 | $3,061 |
| Minoxidil | Generic | 21 | 0 | $359 |
| Betamethasone Diprop Augmented (Betamethasone/Propylene Glyc) | Brand | 18 | 0 | $321 |
| Doxycycline Hyclate | Generic | 17 | 0 | $581 |
| Fluocinonide | Generic | 17 | 0 | $408 |
| Cephalexin | Generic | 14 | 0 | $965 |
| Finasteride | Generic | 14 | 0 | $199 |
Frequently asked questions
What is Dr. Mary Parker's medical specialty?
Dr. Mary Parker practices Specialist in Houston, TX.
Where does Dr. Mary Parker practice?
Dr. Mary Parker practices at 7737 Southwest Fwy, Houston, TX 770741807. Office phone: 7139814444.
What is Dr. Mary Parker's NPI?
Dr. Mary Parker's National Provider Identifier (NPI) is 1568773273, issued by NPPES.
Does Dr. Mary Parker accept Medicare assignment?
Yes. Dr. Mary Parker accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Mary Parker commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Destruction of precancer skin growth, 1 growth (HCPCS 17000); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.